Shubhi Saxena | Pharmaceutical Sciences | Young Researcher Award

Published on by Young Scientists Awards

Young Researcher Award

Shubhi Saxena
Researcher Shubhi Saxena
Affiliation Chitkara University, Punjab
Country India
Scopus ID 59249007100
Documents 11
Citations 29
h-index 3
Subject Area Pharmaceutical Sciences
Event International Young Scientists Award

Shubhi Saxena

Chitkara University, Punjab, India

Shubhi Saxena, affiliated with Chitkara University, Punjab, has established an emerging research profile within the field of Pharmaceutical Sciences through peer-reviewed publications and scholarly activities. The available bibliometric indicators, including research publications, citations, and h-index, reflect growing academic visibility and an active commitment to advancing pharmaceutical research. Such achievements represent important indicators of research productivity and scholarly influence while supporting continued development in scientific investigation and interdisciplinary collaboration.[1]

Abstract

Shubhi Saxena has contributed to Pharmaceutical Sciences through research publications addressing contemporary scientific and healthcare challenges. Her scholarly record demonstrates consistent participation in research activities, publication in indexed journals, and collaboration within the academic community. Bibliometric indicators available through Scopus show an emerging citation profile that reflects the visibility of her published work. These achievements indicate a commitment to evidence-based research, scientific communication, and continuous professional development, making her research profile suitable for recognition within programs supporting early-career scientific excellence.[1]

Keywords

  • Young Researcher Award
  • Pharmaceutical Sciences
  • Scientific Research
  • Research Publications
  • Academic Excellence
  • Scopus Author

Introduction

Recognition programs for early-career researchers encourage scientific excellence by acknowledging individuals who contribute to research, innovation, and knowledge dissemination. Within Pharmaceutical Sciences, sustained research efforts are essential for improving healthcare outcomes, developing therapeutic strategies, and expanding scientific understanding. Researchers demonstrating consistent publication activity, measurable research impact, and active academic engagement represent valuable contributors to the advancement of science. Academic awards provide encouragement for continued excellence while highlighting contributions that support future scientific progress.[2]

Research Profile

Shubhi Saxena is affiliated with Chitkara University, Punjab, India. According to the available Scopus author profile, her scholarly record includes 11 indexed publications, 29 citations, and an h-index of 3. These indicators demonstrate developing academic visibility and participation in peer-reviewed scientific communication. Her research activities contribute to Pharmaceutical Sciences through investigations that support evidence-based practice and knowledge generation. Continued publication and collaboration are expected to strengthen her academic profile over time.[1]

Research Contributions

The research contributions associated with Shubhi Saxena reflect active participation in pharmaceutical investigations and scientific publication. Through peer-reviewed articles, she has supported the dissemination of research findings relevant to pharmaceutical science and related interdisciplinary fields. Such contributions enhance scientific discussion, encourage collaborative research, and provide valuable references for future investigations. The growing citation record indicates that published studies are being consulted by the wider research community.[3]

Publications

The available Scopus profile records 11 indexed publications covering Pharmaceutical Sciences and related research topics. Publication within recognized scientific journals demonstrates adherence to peer-review standards and contributes to the dissemination of validated scientific knowledge. Indexed publications also improve research accessibility and encourage future scholarly collaboration through citation and academic engagement.[1]

Research Impact

Bibliometric indicators represent one measure of research influence within the scientific community. The current citation count of 29 and an h-index of 3 indicate that the published work has received scholarly attention while demonstrating continuing research visibility. Although quantitative metrics do not fully capture scientific quality, they provide objective evidence of publication usage, citation activity, and academic engagement within Pharmaceutical Sciences.[1]

Award Suitability

Based on the available academic information, Shubhi Saxena demonstrates characteristics commonly associated with emerging research excellence. Her publication record, citation performance, institutional affiliation, and continued participation in scientific research align with the objectives of the International Young Scientists Award. Recognition through the Young Researcher Award would acknowledge demonstrated scholarly productivity while encouraging future contributions to Pharmaceutical Sciences and interdisciplinary scientific research.[2]

Conclusion

Shubhi Saxena has developed a growing academic profile through research publications, measurable citation impact, and active engagement in Pharmaceutical Sciences. Her scholarly achievements demonstrate commitment to scientific investigation, publication, and knowledge dissemination. The available bibliometric evidence supports recognition as an emerging researcher while encouraging continued contributions to academic research, innovation, and professional development within the global scientific community.[1]

External Link

References

  1. Elsevier. (n.d.). Scopus Author Details: Shubhi Saxena, Author ID 59249007100. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=59249007100
  2. Young Scientist Awards. (n.d.). International Young Scientists Award – Award Information.
    https://youngscientistawards.com/
  3. Beyond the brain barrier: Hybrid nanoparticles orchestrating intelligent neuro-theranostics.
    https://www.sciencedirect.com/science/article/pii/S000186862600179X

Akash Vikal | Pharmacology | Young Scientist Award

Published on by Young Scientists Awards

Young Scientist Award

Akash Vikal
IFTM University, Moradabad, UP, INDIA
Akash Vikal
Affiliation IFTM University, Moradabad, UP, INDIA
Country India
Scopus ID 59193441600
Documents 28
Citations 255
h-index 7
Subject Area Pharmacology
Event International Young Scientist Awards
ORCID 0009-0003-6893-2971

The Young Scientist Award recognition highlights the academic and scientific contributions of Akash Vikal, affiliated with IFTM University, Moradabad, India. His scholarly profile demonstrates continued engagement in pharmacological research, with notable contributions in pharmaceutical sciences, drug delivery systems, and emerging therapeutic methodologies. The recognition reflects measurable research productivity indexed within international academic databases, including Scopus and Google Scholar.[1]

Abstract

Akash Vikal has contributed to the field of pharmacology through academic publications and interdisciplinary research activities focused on pharmaceutical formulations, therapeutic technologies, and biomedical applications. His publication record indexed within Scopus demonstrates sustained scholarly participation and measurable citation performance. The Young Scientist Award recognition acknowledges research productivity, scientific engagement, and the broader academic relevance of his work within pharmaceutical and biomedical sciences.[2]

Keywords

Pharmacology, Pharmaceutical Sciences, Drug Delivery Systems, Biomedical Research, Therapeutics, Nanomedicine, Academic Research, Scopus Publications, Citation Impact, Young Scientist Award

Introduction

The International Young Scientist Awards recognize emerging researchers demonstrating meaningful academic contributions within their respective scientific disciplines. Researchers selected for recognition are generally evaluated based on publication output, citation metrics, academic influence, and participation in scientific advancement. In this context, Akash Vikal has established a developing research profile within pharmacology and related biomedical domains through peer-reviewed publications and scholarly collaborations.[3]

Modern pharmaceutical research increasingly emphasizes interdisciplinary approaches integrating chemistry, biotechnology, and clinical therapeutics. The researcher’s documented academic activities align with these evolving scientific trends and reflect participation in ongoing developments associated with pharmaceutical innovation and translational medicine.[4]

Research Profile

Akash Vikal is affiliated with IFTM University located in Moradabad, Uttar Pradesh, India. His indexed academic profile indicates publication activity primarily related to pharmacology and pharmaceutical sciences. According to Scopus indexing data, the researcher has authored or co-authored 28 academic documents, receiving approximately 255 citations with an h-index value of 7.[1]

  • Primary discipline: Pharmacology
  • Institutional affiliation: IFTM University
  • Research indexing database: Scopus
  • International research visibility through ORCID and Google Scholar

Research Contributions

The researcher’s academic contributions are associated with pharmaceutical technologies, therapeutic formulation strategies, and biomedical research methodologies. Several publications explore emerging pharmaceutical approaches relevant to drug delivery systems and modern therapeutic interventions. Such contributions are significant within pharmacological research because they support ongoing efforts toward improving efficacy, bioavailability, and targeted therapeutic applications.[5]

Research activities further demonstrate interdisciplinary engagement involving pharmaceutical chemistry, biomedical sciences, and nanotechnology-related therapeutic studies. The integration of scientific methodologies across these domains reflects broader contemporary directions in pharmaceutical innovation and translational medical research.[6]

  • Research participation in pharmaceutical formulation studies
  • Academic engagement in therapeutic innovation research
  • Interdisciplinary scientific collaboration
  • Indexed publication contributions in biomedical sciences

Publications

The publication portfolio of Akash Vikal includes research articles and scholarly works indexed within recognized academic databases. Selected research outputs demonstrate involvement in pharmaceutical sciences and therapeutic innovation studies.[2]

  1. Research studies associated with pharmaceutical formulations and therapeutic delivery systems.
  2. Publications exploring nanotechnology-assisted therapeutic methodologies and biomedical applications.
  3. Academic articles indexed in Scopus and referenced through citation databases.

Representative DOI-linked publications and indexed records contribute to the visibility and traceability of the researcher’s scientific output.[7]

Research Impact

Research impact indicators are commonly evaluated through publication volume, citation frequency, and h-index metrics. Akash Vikal’s citation profile demonstrates measurable academic engagement within the pharmaceutical research community. Citation-based indicators suggest that the published work has achieved scholarly visibility and reference within relevant scientific literature.[1]

Metric Value
Documents 28
Citations 255
h-index 7
Primary Subject Area Pharmacology

Award Suitability

The Young Scientist Award is generally intended to recognize early-career or emerging researchers demonstrating promising scholarly achievements and research visibility. Based on indexed publication output, citation performance, and participation in pharmaceutical research activities, Akash Vikal’s academic profile aligns with the evaluative framework commonly associated with international young researcher recognitions.[3]

The researcher’s documented scientific activities indicate continued engagement in pharmacological and biomedical investigations relevant to contemporary therapeutic research priorities. Such scholarly engagement supports the broader objectives of scientific advancement and interdisciplinary academic collaboration.[6]

Conclusion

Akash Vikal has established an emerging academic profile within the field of pharmacology through indexed publications, measurable citation performance, and participation in pharmaceutical research initiatives. The Young Scientist Award recognition reflects scholarly contributions associated with therapeutic innovation, pharmaceutical sciences, and biomedical research. Continued research activity and interdisciplinary collaboration are expected to further strengthen the researcher’s scientific impact and academic visibility.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Akash Vikal, Author ID 59193441600. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=59193441600
  2. Google Scholar. (n.d.). Academic citation profile of Akash Vikal.
    https://scholar.google.com/citations?user=DmTcek4AAAAJ&hl=en&oi=sra
  3. International Young Scientist Awards. (n.d.). Award evaluation and recognition criteria.
    https://youngscientistawards.com/
  4. Allen, T. M., & Cullis, P. R. (2013). Liposomal drug delivery systems: From concept to clinical applications.DOI: https://doi.org/10.1016/S0140-6736(13)61809-7
  5. Patra, J. K., et al. (2018). Nano based drug delivery systems: Recent developments and future prospects.DOI: https://doi.org/10.1016/j.jconrel.2018.10.015
  6. Peer, D., et al. (2007). Nanocarriers as an emerging platform for cancer therapy.DOI: https://doi.org/10.1038/nnano.2007.387
  7. Torchilin, V. P. (2014). Multifunctional nanocarriers.DOI: https://doi.org/10.1038/nrd.2014.73

Shumaila Zulfiqar | Human Genetics | Young Researcher Award

Published on by Young Scientists Awards

Dr. Shumaila Zulfiqar | Human Genetics | Young Researcher Award

Kinnaird College for Women University | Pakistan

Dr. Shumaila Zulfiqar is a researcher in biotechnology and human genetics, specializing in the molecular basis of rare neurogenetic, ocular, and autoinflammatory disorders. Her work integrates whole exome sequencing, bioinformatics, and functional genomics to identify novel disease-causing variants and expand genotype–phenotype correlations in underrepresented populations. She has contributed significantly to genomic medicine through variant discovery, clinical interpretation, and data submission to global databases. Her research also extends to immunogenomics and precision diagnostics, aiming to bridge genetic findings with clinical applications. With a growing publication record, including 11 documents, 76 citations across 72 documents, and an h-index of 4, her work reflects strong scientific impact and international collaboration.

Citation Metrics (Scopus)

250

200

150

100

50

0

Citations
76

Documents
11

h-index
4

 


View Scopus Profile View Orcid Profile View Google Scholar Profile

Featured Publications


Investigation of prevalence and awareness of polycystic ovary syndrome among Pakistani females

– Proceedings of the Pakistan Academy of Sciences, 2022 | Citations: 16


A cross-sectional study elucidating associated predictors in postpartum depression among Pakistani women

– Proceedings of the Pakistan Academy of Sciences, 2023 | Citations: 7

Azhar Mehmood | Cancer Genetics | Best Researcher Award

Published on by Young Scientists Awards

Dr. Azhar Mehmood | Cancer Genetics
| Best Researcher Award

Rawalpindi Medical University | Pakistan

Dr. Azhar Mehmood is a biochemistry and molecular biology researcher whose work spans cancer genetics, DNA damage response pathways, exosomal biomarker discovery, and infectious disease molecular diagnostics. His research contributions include extensive investigation of breast, gastric, thyroid, and head and neck cancers, with a strong emphasis on genetic polymorphisms, pathway deregulation, epigenetic mechanisms, and survival-associated molecular markers. He has explored the prognostic significance of DDR pathway genes, including ATM, ATR, Chk1, and SIRT3/FOXO3a/SOD2 regulatory axes, and conducted SNP-based risk analyses for various malignancies. His work on exosomal microRNAs—such as miR-19a/b, miR-144-3p, miR-4262, and the miR-17-92a cluster—has advanced understanding of their diagnostic and therapeutic potential in breast and brain tumors. His research background also includes contributions to molecular profiling of HCV persistence, viral immunology, and transfusion-transmitted infections. He has applied molecular techniques such as qPCR, LORD-qPCR, IHC, ELISA, genotyping, exosome characterization, and multiple biochemical assays to uncover disease mechanisms and improve diagnostic precision. His publications collectively highlight a strong focus on cancer risk assessment, biomarker identification, and translational molecular research aimed at supporting early detection, targeted therapy development, and improved patient outcomes across multiple cancer types.

Featured Publications

Haris, M. S., Hussain, M. Z., Mehmood, A., Kayani, M. A., & Mahjabeen, I. (2025). hsa-miR-144-3p and hsa-miR-4262 are exosomal biomarkers and function as tumor suppressors in HCMV positive brain tumor. Future Oncology. https://doi.org/10.1080/14796694.2025.2569097

Mehmood, A., Mahjabeen, I., Reed, S., Errington, R. J., Umar, M., Pervaiz, F., & Kayani, M. A. (2025). Association of DDR pathway proteins and breast cancer risk in a Pakistani population. Future Oncology. https://doi.org/10.1080/14796694.2025.2581508